GlassScriptPhysician profile
Scott R Price
NPI 1417067455
$840.68
in general payments reported to CMS, 2019-2025
19 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.04 · 2020: $70.21 · 2021: $113 · 2022: $250 · 2023: $76.82 · 2024: $87.33 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $142.13 | 2022-2023 | Surgx, Xperience, Blastx |
| Organogenesis INC. | $93.26 | 2020-2023 | Puraply |
| Aap Implants INC | $79.39 | 2022 | |
| Paratek Pharmaceuticals, INC. | $71.54 | 2024-2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $63.60 | 2019 | |
| Smith+Nephew, INC. | $48.05 | 2021-2024 | Hat-Trick, Evos |
| Averitas Pharma INC. | $42.18 | 2024 | Qutenza |
| Mimedx Group, INC. | $38.79 | 2025 | |
| Orthofix Medical, INC. | $37.56 | 2020-2021 | |
| Surgenex LLC | $31.86 | 2025 | Ardeograft, Surgraft, Pellograft |
| Avanos Medical | $28.20 | 2022 | |
| Tactile Systems Technology INC | $26.32 | 2020-2021 | |
| Alfasigma USA, INC. | $22.87 | 2020 | |
| Kerecis Limited | $22.48 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Melinta Therapeutics, LLC | $22.44 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $19.74 | 2025 | Bio-Connekt |
| Bioventus LLC | $19.64 | 2021 | |
| Djo, LLC | $15.36 | 2025 | Cmf |
| Abbott Laboratories | $15.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.